FDA announces a two-day (10/15-16) public Webinar on New Approaches for an Integrated Nonclinical-Clinical QT/Proarrhythmic Risk Assessment.
FDA says it now recommends that people in seven high-risk categories refrain from exposure to dental mercury amalgam when possible.
Prompted by TikTok-posted teenager challenges, a new FDA safety alert warns that taking higher than recommended doses of Benadryl (diphenhydramine) ca...
FDA grants Leap Therapeutics a fast track designation for DKN-01 and its use in treating certain patients with gastric and gastroesophageal junction a...
A coalition of 49 state attorneys general reach agreement that requires C.R. Bard and its parent company, Becton, Dickinson, to pay $60 million for th...
The Justice Department says Gilead is paying $97 million to resolve charges it illegally used a foundation to pay Medicare patients copays for the com...
FDA and HHS announce a final rule that allows FDA-authorized programs to import certain prescription drugs from Canada if specific conditions to ensur...
Novartis Gene Therapies says it will conduct an FDA-recommended pivotal confirmatory study of its AVXS-101 intrathecal formulation in older patients w...